NBI‐98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double‐blind, placebo‐controlled study-Reference-Cited by-同舟云学术

NBI‐98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double‐blind, placebo‐controlled study

Published:2015-09-08 Issue:12 Volume:30 Page:1681-1687
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

O'Brien Christopher F.¹,Jimenez Roland¹,Hauser Robert A.²,Factor Stewart A.³,Burke Joshua¹,Mandri Daniel⁴,Castro‐Gayol Julio C.⁵

Affiliation:

1. Neurocrine BiosciencesSan Diego California USA

2. University of South FloridaTampa Florida USA

3. Emory UniversityAtlanta Georgia USA

4. Biscayne Bay InstituteMiami Florida USA

5. Research in MiamiMiami Florida USA

Funder

Neurocrine Biosciences, Inc.

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.26330

Reference22 articles.

1. Tardive dyskinesia and new antipsychotics

2. Incidence of Tardive Dyskinesia With Atypical Versus Conventional Antipsychotic Medications

3. An update on tardive dyskinesia: from phenomenology to treatment;Waln O;Tremor Other Hyperkinet Mov (N Y),2013

4. Life-threatening tardive dyskinesia caused by metoclopramide

5. GuyW ed.ECDEU Assessment Manual of Psychopharmacology. National Institute of Mental Health (U.S.) Psychopharmacology Research Branch Division of Extramural Research Programs 1976.

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mining of neurological adverse events associated with valbenazine: A post-marketing analysis based on FDA adverse event reporting system;General Hospital Psychiatry;2024-09

2. Efficacy and Safety of Valbenazine in Elderly and Nonelderly Japanese Patients With Tardive Dyskinesia;Journal of Clinical Psychopharmacology;2024-08-27

3. Efficacy and safety of different pharmacological interventions in the treatment of tardive dyskinesia: a systematic review and network meta-analysis;European Journal of Clinical Pharmacology;2024-07-06

4. Tardive Dyskinesia with Antipsychotic Medication in Children and Adolescents: A Systematic Literature Review;Drug Safety;2024-06-11

5. Sustained Treatment Response and Global Improvements With Long-term Valbenazine in Patients With Tardive Dyskinesia;Journal of Clinical Psychopharmacology;2024-05-20